// App-Quantinova.ai

18404 : Clinical Events Avoided With Apixaban Compared to Current Standard of Care for the Initial and Extended Treatment and Prevention of Venous Thromboembolism

Researchers

Presenter

  • Melissa Hamilton

Principal Investigators

  • Dale Rublee

  • Robert Leipold

  • Chantelle Browne

  • Peter Quon

  • Ander Cohen

Medical Centers

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • Pfizer Inc.

  • Evidera, Inc.

  • Bristol-Myers Squibb

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved